tiprankstipranks
Trending News
More News >
Cannabist Company Holdings Inc (TSE:CBST)
:CBST

Cannabist Company Holdings (CBST) AI Stock Analysis

Compare
50 Followers

Top Page

TS

Cannabist Company Holdings

(OTC:CBST)

42Neutral
Cannabist Company Holdings is currently facing substantial financial difficulties, highlighted by declining revenues, negative cash flows, and high leverage. While technical indicators show limited momentum, they also hint at potential downside risks. Although recent corporate events suggest strategic efforts to improve market position and financial health, these initiatives need time to materialize. Overall, the stock presents significant risks with limited immediate upside potential.
Positive Factors
Expansion and Acquisitions
Verano set to expand operations in Arizona and enter Virginia via acquisitions with The Cannabist Co.
Financial Benefit
The transaction terms indicate potential financial benefit for CBST through cash and voting shares.
Negative Factors
Asset Dispositions
CBST progresses on previously announced planned asset dispositions.

Cannabist Company Holdings (CBST) vs. S&P 500 (SPY)

Cannabist Company Holdings Business Overview & Revenue Model

Company DescriptionCannabist Company Holdings (CBST) is a diversified cannabis company that operates in multiple sectors of the cannabis industry, including cultivation, manufacturing, distribution, and retail. The company is committed to providing high-quality cannabis products and services to its customers and operates a range of dispensaries under the Cannabist brand. CBST's core products include a variety of cannabis strains, edibles, concentrates, and other related products tailored to both medical and recreational markets.
How the Company Makes MoneyCannabist Company Holdings makes money through several key revenue streams. The primary source of revenue is the sale of cannabis products through its retail dispensaries, where they offer a range of products including flowers, edibles, concentrates, and topicals. Additionally, the company generates income from its wholesale operations, supplying cannabis products to other dispensaries and businesses. CBST also benefits from its cultivation and manufacturing segments, which ensure a consistent supply of high-quality products and allow for vertical integration, reducing costs and increasing margins. Strategic partnerships and licensing agreements further enhance the company's revenue potential by expanding market reach and product offerings.

Cannabist Company Holdings Financial Statement Overview

Summary
Cannabist Company Holdings faces significant financial challenges. The income statement reflects declining revenue and persistent losses, while the balance sheet shows high leverage and low equity, posing risks to financial stability. Cash flow constraints further exacerbate the company's financial position. Strategic restructuring and improved operational efficiency are needed to drive financial recovery and growth.
Income Statement
40
Negative
Cannabist Company Holdings has experienced declining revenue in the TTM compared to the previous year, with a negative revenue growth rate of -3.41%. The gross profit margin for TTM is 33.60%, which is relatively stable, but the net profit margin remains negative at -25.49%, indicating persistent losses. EBIT and EBITDA margins are also negative, reflecting operational challenges. The company needs to address its profitability issues to improve its financial health.
Balance Sheet
35
Negative
The company's balance sheet shows significant leverage, with a debt-to-equity ratio of 19.25 in the TTM, indicating high financial risk. The equity ratio is low at 3.22%, suggesting limited buffer against liabilities. Return on equity is negative, pointing to ongoing unprofitability. The company must focus on reducing debt and improving equity to enhance stability.
Cash Flow
30
Negative
Cannabist's cash flow position is concerning, with a negative free cash flow of -23.99 million in the TTM, and no meaningful free cash flow growth. The operating cash flow to net income ratio is negative, reflecting cash flow issues. These indicate challenges in generating sufficient cash to cover operations and investments, necessitating strategic adjustments to improve liquidity.
Breakdown
Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Income StatementTotal Revenue
511.33M491.31M456.03M188.99M79.26M
Gross Profit
179.97M136.13M146.92M52.68M13.47M
EBIT
-105.24M-73.10M-37.70M-84.45M-96.30M
EBITDA
-51.30M-282.36M-63.14M-115.66M-95.21M
Net Income Common Stockholders
-175.71M-399.52M-141.84M-100.85M-104.97M
Balance SheetCash, Cash Equivalents and Short-Term Investments
36.91M48.13M82.09M61.11M47.46M
Total Assets
823.11M994.28M1.37B727.53M402.28M
Total Debt
546.32M566.97M420.75M295.21M83.64M
Net Debt
510.56M518.84M338.66M234.10M36.18M
Total Liabilities
757.76M787.47M824.57M440.58M135.34M
Stockholders Equity
66.53M213.19M570.62M306.82M268.27M
Cash FlowFree Cash Flow
-2.50M-179.70M-132.64M-97.42M-140.38M
Operating Cash Flow
7.47M-106.99M-518.40K-52.27M-61.13M
Investing Cash Flow
-3.50M-72.34M-189.67M-24.02M-93.38M
Financing Cash Flow
-14.12M147.59M200.66M90.00M155.76M

Cannabist Company Holdings Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.56
Price Trends
50DMA
0.56
Positive
100DMA
0.56
Negative
200DMA
0.56
Negative
Market Momentum
MACD
>-0.01
Neutral
RSI
100.00
Negative
STOCH
66.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CBST, the sentiment is Negative. The current price of 0.56 is below the 20-day moving average (MA) of 0.56, above the 50-day MA of 0.56, and below the 200-day MA of 0.56, indicating a neutral trend. The MACD of >-0.01 indicates Neutral momentum. The RSI at 100.00 is Negative, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:CBST.

Cannabist Company Holdings Peers Comparison

Overall Rating
UnderperformOutperform
Sector (52)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
56
Neutral
C$1.23B-12.12%6.27%67.62%
56
Neutral
$988.67M-23.33%0.67%19.14%
TSOGI
53
Neutral
$200.75M-18.27%7.33%84.41%
52
Neutral
$5.35B3.96-42.60%2.86%17.58%1.27%
TSACB
50
Neutral
$325.46M25.514.78%16.39%-98.10%
47
Neutral
$335.02M-84.50%-16.27%
42
Neutral
C$227.80M-554.70%-9.05%45.26%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:CBST
Cannabist Company Holdings
0.56
0.00
0.00%
TSE:WEED
Canopy Growth
1.85
-11.46
-86.10%
TSE:ACB
Aurora Cannabis
6.69
-2.41
-26.48%
TSE:TRUL
Trulieve Cannabis
6.44
-8.73
-57.55%
TSE:OGI
OrganiGram Holdings
1.59
-0.99
-38.37%
TSE:CURA
Curaleaf Holdings
1.31
-6.37
-82.94%

Cannabist Company Holdings Earnings Call Summary

Earnings Call Date:Mar 13, 2025
(Q3-2024)
|
% Change Since: 0.00%|
Next Earnings Date:May 08, 2025
Earnings Call Sentiment Neutral
The earnings call reflects a company in the midst of a significant transformation, with strategic divestitures aimed at addressing liquidity and debt challenges. While there is positive momentum in wholesale growth and market transitions, revenue and cash flow challenges remain. The sentiment is cautious as the company navigates through these structural changes.
Q3-2024 Updates
Positive Updates
Transformation Progress and Strategic Divestitures
The company made significant progress in its transformation plan, having completed the sale of assets and operations in Arizona and Eastern Virginia for $105 million. This strategic move helped solve near-term liquidity needs and set the stage for tackling future debt obligations.
Wholesale Revenue Growth
Sequential increase in wholesale revenue by 2% to $19.5 million, despite impactful divestitures in Virginia and Arizona.
Ohio Market Transition to Adult Use
The transition of the Ohio market to adult use resulted in volumes on average nearly doubling and a new customer rate nearly nine times greater than prior to the transition.
Cost-Cutting and Operational Improvements
Further operational improvements and additional cost-cutting initiatives implemented in Q4 to drive efficiencies, including a $10 million annualized cost savings from corporate restructuring actions.
Negative Updates
Revenue Decline
Third-quarter revenue was $115 million, down 8% from the second quarter, primarily due to the sale of Eastern Virginia and Arizona businesses.
Negative Cash Flow from Operations
Cash from operations was negative $18 million in the third quarter, compared to negative $3 million in the second quarter, due to deferred payments, divestitures, and restructuring efforts.
Adjusted EBITDA Decline
Adjusted EBITDA fell to $14 million from $17.5 million in Q2, with the margin decreasing from 14% to 13%, impacted by the divestitures of high-margin businesses in Virginia and Arizona.
Company Guidance
In the third quarter of 2024, The Cannabist Company provided comprehensive guidance focusing on strategic divestitures and operational improvements to enhance profitability and sustainability. The company completed significant asset sales in Arizona and Virginia, generating $105 million to address liquidity needs and future debt obligations. Additionally, efforts to exit Florida and streamline operations in DC and Massachusetts were highlighted. Despite the temporary impact on bottom-line results due to these divestitures, the company achieved $115 million in revenue with a 38.2% gross margin. Wholesale revenue increased by 2% sequentially, reaching $19.5 million. The company set a target of a 20% adjusted EBITDA margin by 2025, reflecting a clear strategy to focus on high-potential markets like Ohio, which saw revenues nearly double with the transition to adult use. The company plans to continue rationalizing its geographic footprint, enhancing wholesale operations, and leveraging capital to deleverage the balance sheet while opening new retail locations in New Jersey, Maryland, Virginia, and Ohio.

Cannabist Company Holdings Corporate Events

Private Placements and FinancingBusiness Operations and Strategy
Cannabist Company Secures Noteholder Approval for Financial Restructuring
Neutral
Apr 29, 2025

The Cannabist Company has received approval from its senior noteholders for a plan of arrangement that involves exchanging existing senior notes for new ones due in 2028 and issuing new common shares and warrants. This approval, which surpassed the required two-thirds majority, marks a significant step for the company, although the arrangement still requires court approval and faces opposition from a holder of the 2025 notes. The outcome of this arrangement could impact the company’s financial restructuring and its position in the cannabis industry.

Spark’s Take on TSE:CBST Stock

According to Spark, TipRanks’ AI Analyst, TSE:CBST is a Neutral.

Cannabist Company Holdings is currently facing substantial financial difficulties, highlighted by declining revenues, negative cash flows, and high leverage. While technical indicators show limited momentum, they also hint at potential downside risks. Although recent corporate events suggest strategic efforts to improve market position and financial health, these initiatives need time to materialize. Overall, the stock presents significant risks with limited immediate upside potential.

To see Spark’s full report on TSE:CBST stock, click here.

Product-Related AnnouncementsBusiness Operations and Strategy
Cannabist Company Expands Adult-Use Cannabis Sales in New Jersey
Positive
Apr 22, 2025

The Cannabist Company has announced the launch of adult-use cannabis sales at its Mays Landing dispensary in New Jersey, marking its third location in the state. This expansion strengthens the company’s retail presence and supports its commitment to providing high-quality cannabis products to both medical and adult-use consumers. The grand opening event will feature promotions and a guest appearance by Ric Flair, enhancing community engagement and brand visibility. The company’s recent upgrades to its Vineland facilities further bolster its capacity to meet growing demand, positioning it favorably in the competitive cannabis market.

Spark’s Take on TSE:CBST Stock

According to Spark, TipRanks’ AI Analyst, TSE:CBST is a Neutral.

Cannabist Company Holdings is currently facing substantial financial difficulties, highlighted by declining revenues, negative cash flows, and high leverage. While technical indicators show limited momentum, they also hint at potential downside risks. Although recent corporate events suggest strategic efforts to improve market position and financial health, these initiatives need time to materialize. Overall, the stock presents significant risks with limited immediate upside potential.

To see Spark’s full report on TSE:CBST stock, click here.

Business Operations and Strategy
Cannabist Company Holdings Announces Strategic Initiative to Boost Market Presence
Positive
Apr 8, 2025

Cannabist Company Holdings has announced a strategic initiative aimed at enhancing its market presence and operational efficiency. This move is expected to strengthen the company’s position in the cannabis industry by optimizing its resources and expanding its market reach, potentially benefiting stakeholders through improved performance and growth prospects.

Spark’s Take on TSE:CBST Stock

According to Spark, TipRanks’ AI Analyst, TSE:CBST is a Underperform.

Cannabist Company Holdings is grappling with significant financial difficulties, including declining revenues and negative cash flows. Despite strategic efforts to restructure and improve financial health, the stock remains unattractive due to its weak financial position and valuation metrics. Technical indicators show limited momentum, further weighing down the stock’s appeal.

To see Spark’s full report on TSE:CBST stock, click here.

Legal ProceedingsShareholder MeetingsBusiness Operations and Strategy
Cannabist Company Secures Interim Court Order for Strategic Arrangement
Neutral
Mar 31, 2025

The Cannabist Company announced that the Ontario Superior Court of Justice has granted an interim order for its plan of arrangement under the Canada Business Corporations Act. This plan involves the company and its subsidiaries, with a special meeting scheduled for Senior Noteholders to vote on the transaction. The transaction requires a two-thirds majority vote from Senior Noteholders and a final court order for approval. The outcome of this arrangement could significantly impact the company’s financial structure and market positioning.

Business Operations and StrategyFinancial Disclosures
The Cannabist Company Reports 2024 Financial Results Amid Strategic Transformation
Negative
Mar 13, 2025

The Cannabist Company reported a challenging financial performance for the fourth quarter and full year of 2024, with a decline in revenue and net income. Despite these results, the company is undergoing a transformation, implementing structural changes, and extending debt maturities to focus on optimizing operations and reducing costs. The company aims to simplify its business and improve financial performance in 2025, with plans to expand in Delaware, Virginia, and Ohio.

Private Placements and FinancingBusiness Operations and Strategy
Cannabist Company Extends Senior Secured Notes Maturity to 2028
Positive
Feb 27, 2025

The Cannabist Company Holdings Inc. announced an agreement to extend the maturity date of its senior secured notes to December 2028, with options to extend through 2029. This strategic move is part of the company’s ongoing efforts to optimize its operations and financial structure, providing it with the flexibility to pursue growth opportunities and operational improvements. The transaction, which involves exchanging existing notes for new ones with extended maturity dates, is subject to court approval and reflects the company’s proactive approach to managing its financial obligations and strengthening its market position.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.